Patients with diagnosis of prostate cancer

With age between 18-75 years classified in low

Intermediate and high-risk group according to their Gleason score

T stage and initial PSA (iPSA).

Low risk group included patients with Gleason score \<7 / stage T1-T2a, and iPSA \<10 ng/mL.

Intermediate risk included Gleason score \< 7, or Stage T1-T2b, or iPSA level of 10-20 ng/mL

High-risk patients with Gleason score \>7, or Stage \> T2b, or iPSA \>20 ng/mL.

All patients classified as high risk was submitted to the bone scans.

Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule